204 related articles for article (PubMed ID: 36438711)
1. Predictive value of indirect bilirubin before neoadjuvant chemoradiotherapy in evaluating prognosis of local advanced rectal cancer patients.
Li SF; Wei R; Yu GH; Jiang Z
World J Gastrointest Oncol; 2022 Nov; 14(11):2224-2237. PubMed ID: 36438711
[TBL] [Abstract][Full Text] [Related]
2. Predictive Value of the Neutrophil-Lymphocyte Ratio for Tumor Regression Grade and Prognosis of Local Advanced Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.
Li S; Wang D; Wei R; Yu G; Wang X; Jiang Z
Technol Cancer Res Treat; 2023; 22():15330338231202611. PubMed ID: 37807729
[TBL] [Abstract][Full Text] [Related]
3. BMI May Be a Prognostic Factor for Local Advanced Rectal Cancer Patients Treated with Long-Term Neoadjuvant Chemoradiotherapy.
Liu H; Wei R; Li C; Zhao Z; Guan X; Yang M; Liu Z; Wang X; Jiang Z
Cancer Manag Res; 2020; 12():10321-10332. PubMed ID: 33116887
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of mesorectal package area in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy: A retrospective cohort study.
Guan B; Huang X; Xia H; Guan G; Xu B
Front Oncol; 2022; 12():941786. PubMed ID: 36263216
[TBL] [Abstract][Full Text] [Related]
5. Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy.
Lu S; Liu Z; Zhou X; Wang B; Li F; Ma Y; Wang W; Ma J; Wang Y; Wang H; Fu W
Cancer Manag Res; 2020; 12():8555-8568. PubMed ID: 32982448
[TBL] [Abstract][Full Text] [Related]
6. Lymph Node Regression to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: Prognostic Implication and a Predictive Model.
Sun Y; Wu X; Lin H; Lu X; Huang Y; Chi P
J Gastrointest Surg; 2021 Apr; 25(4):1019-1028. PubMed ID: 32219686
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of a serum tumor biomarkers scoring system for clinical stage II/III rectal cancer with neoadjuvant chemoradiotherapy.
Zhao JY; Tang QQ; Luo YT; Wang SM; Zhu XR; Wang XY
World J Gastrointest Oncol; 2022 Oct; 14(10):2014-2024. PubMed ID: 36310703
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of changes in the level of carbohydrate antigen 19-9 in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Zheng Z; Wang X; Huang Y; Lu X; Chi P
Colorectal Dis; 2020 Dec; 22(12):2068-2077. PubMed ID: 32936987
[TBL] [Abstract][Full Text] [Related]
9. Changes in serum uric acid, serum uric acid/serum creatinine ratio, and gamma-glutamyltransferase might predict the efficacy of neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
Shao Z; Xu Y; Zhang X; Zou C; Xie R
Strahlenther Onkol; 2024 Jun; 200(6):523-534. PubMed ID: 37286741
[TBL] [Abstract][Full Text] [Related]
10. The Predictive Value of Pre-/Postneoadjuvant Chemoradiotherapy MRI Characteristics for Patient Outcomes in Locally Advanced Rectal Cancer.
Meng Y; Wan L; Zhang C; Wang C; Ye F; Li S; Zou S; Cheng J; Xu K; Zhou C; Zhang H
Acad Radiol; 2020 Sep; 27(9):e233-e243. PubMed ID: 31780392
[TBL] [Abstract][Full Text] [Related]
11. Combined Detection of RUNX3 and EZH2 in Evaluating Efficacy of Neoadjuvant Therapy and Prognostic Value of Middle and Low Locally Advanced Rectal Cancer.
Wang L; Wu X; Xu W; Gao L; Wang X; Li T
Front Oncol; 2022; 12():713335. PubMed ID: 35280723
[TBL] [Abstract][Full Text] [Related]
12. The prognostic role of the change in albumin-derived neutrophil-to-lymphocyte ratio during neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
Pan Z; Wang Y; Li S; Cai H; Guan G
Biomol Biomed; 2024 May; 24(3):612-624. PubMed ID: 38041687
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of neoadjuvant rectal score-based signature nomograms to predict overall survival and disease-free survival in locally advanced rectal cancer: a retrospective, double center, cohort study.
Wang G; Tang Z; Ye J; Tang H; Yao K; Zeng Q; Yang Y; Fu M; Luo L; Shen Q; Fang X; Ling B; Fang Y; Guo Y; Huang Y
Int J Clin Oncol; 2023 Feb; 28(2):268-279. PubMed ID: 36534264
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment Albumin-to-Fibrinogen Ratio Independently Predicts Chemotherapy Response and Prognosis in Patients with Locally Advanced Rectal Cancer Undergoing Total Mesorectal Excision After Neoadjuvant Chemoradiotherapy.
Li H; Wang H; Shao S; Gu Y; Yao J; Huang J
Onco Targets Ther; 2020; 13():13121-13130. PubMed ID: 33380802
[TBL] [Abstract][Full Text] [Related]
15. Nomograms and risk score models for predicting survival in rectal cancer patients with neoadjuvant therapy.
Wei FZ; Mei SW; Chen JN; Wang ZJ; Shen HY; Li J; Zhao FQ; Liu Z; Liu Q
World J Gastroenterol; 2020 Nov; 26(42):6638-6657. PubMed ID: 33268952
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of an MRI-Based Nomogram Model for Predicting Disease-Free Survival in Locally Advanced Rectal Cancer Treated With Neoadjuvant Radiotherapy.
Chen S; Tang Y; Li N; Jiang J; Jiang L; Chen B; Fang H; Qi S; Hao J; Lu N; Wang S; Song Y; Liu Y; Li Y; Jin J
Front Oncol; 2021; 11():784156. PubMed ID: 34869040
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of pretreatment systemic inflammatory markers in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy.
Zhang Y; Liu X; Xu M; Chen K; Li S; Guan G
Sci Rep; 2020 May; 10(1):8017. PubMed ID: 32415197
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of neoadjuvant rectal score in locally advanced rectal cancer after neoadjuvant chemoradiotherapy and construction of a prediction model.
Sun Y; Zhang Y; Wu X; Lin H; Lu X; Huang Y; Xu Z; Huang S; Wang X; Chi P
J Surg Oncol; 2018 Mar; 117(4):737-744. PubMed ID: 29228455
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation.
Dudani S; Marginean H; Tang PA; Monzon JG; Raissouni S; Asmis TR; Goodwin RA; Gotfrit J; Cheung WY; Vickers MM
BMC Cancer; 2019 Jul; 19(1):664. PubMed ID: 31277604
[TBL] [Abstract][Full Text] [Related]
20. GOLPH3 overexpression correlates with poor response to neoadjuvant therapy and prognosis in locally advanced rectal cancer.
Zhu K; Zhao Q; Yue J; Shi P; Yan H; Xu X; Wang R
Oncotarget; 2016 Oct; 7(42):68328-68338. PubMed ID: 27634904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
